Andrew Lo - 03 Dec 2021 Form 4/A - Amendment Insider Report for AbCellera Biologics Inc. (ABCL)

Role
Director
Signature
/s/ Tryn Stimart, attorney-in-fact
Issuer symbol
ABCL
Transactions as of
03 Dec 2021
Net transactions value
$0
Form type
4/A - Amendment
Filing time
10 Dec 2021, 13:36:29 UTC
Date Of Original Report
07 Dec 2021
Previous filing
01 Oct 2021
Next filing
03 Jan 2022
SEC
View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction ABCL Share Option (right to buy) Award $0 +91,325 $0.000000 91,325 03 Dec 2021 Common Shares 91,325 $14.02 Direct F1, F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The original option award was listed as 86,938 which is an administrative error due to an incorrect the Black-Scholes calculation. The correct number of awarded options is 91,325.
F2 The shares subject to such option vest and become exercisable annually in substantially equal installments over a three-year period, with the first tranche vested on December 3, 2022, subject to the Reporting Person's continuous service to the Issuer on each such date